News

July 29, 2016July 29, 2016

US DOD Grants $11.5M to Study Lung Diseases in Middle East War Vets

Thanks to $11.5 million in grants from the U.S. Department of Defense, researchers from the National Jewish Health respiratory treatment center in Denver will study why veterans who were deployed to the Middle ... Read more

July 28, 2016July 28, 2016

Therapeutic Targets for Small Cell Lung Cancer Identified by UT Southwestern Medical Center Researchers

Lung Cancer, News

A team of researchers at UT Southwestern Medical Center identified the protein ASCL1 as critical for the development of small cell lung cancer (SCLC); the team also found that the absence of ASCL1 in the lungs ... Read more

July 27, 2016July 27, 2016

AdAlta Goes Public to Speed New Therapies for Lung Fibrosis

Idiopathic Pulmonary Fibrosis, News

AdAlta, a drug company, is looking to raise $10 million with an initial public offering (IPO) on the Australian Securities Exchange. The sum will be used to support trials on AD-114, the company’s lead ... Read more

July 26, 2016July 26, 2016

University of Rochester Medical Center Earns Accreditation for Comprehensive PH Care

News, Pulmonary Hypertension

University of Rochester Medical Center (URMC) is the newest recipient of accreditation as a Comprehensive Care Center by the Pulmonary Hypertension Association (PHA). The awarded accreditation is in recognition of the excellence ... Read more

July 25, 2016July 25, 2016

PUR0200, an Inhaled Bronchodilator for COPD, Shows Promise in Pilot Study

COPD, News

PUR0200, a new dry powder formulation being developed for the treatment of chronic obstructive pulmonary disease (COPD), has shown positive pharmacokinetic results in a Phase 1 pilot study. The results were ... Read more

July 22, 2016July 22, 2016

1 in 12 in Cancer Patients Seen to Develop a Secondary Cancer in Long Term, Especially in Lungs

Lung Cancer, News

A study of long-term outcomes in cancer patients found that nearly 1 in every 12 go on to develop other, unrelated cancers, especially lung cancer. According to researchers at the University of California in Los ... Read more

July 22, 2016July 22, 2016

Older COPD Patients, Opioid Use Could Be Fatal Mix

COPD, News

Recent research suggests that opioid use is associated with increased risk for severe respiratory side effects, including death, among older adults with chronic obstructive pulmonary disease (COPD). The study, “Incident opioid drug use and ... Read more

July 21, 2016July 21, 2016

FDA Grants Fast Track Status to Cystic Fibrosis Therapy QR-010 by ProQR

Cystic Fibrosis, News

ProQR Therapeutics announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its molecule QR-010 for the treatment of cystic fibrosis (CF) patients who have the deltaF508 mutation in ... Read more

July 21, 2016July 21, 2016

Savara Builds on Serendex Acquisition by Advancing Inhaled Therapies for Lung Diseases, Infections

Cystic Fibrosis, News

Savara Pharmaceuticals of Austin, Texas, this week announced that it has fully acquired Serendex Pharmaceuticals, a Danish company, adding to its pipeline of specialty products to treat rare respiratory diseases, and noting three candidates in its drug portfolio ... Read more

July 20, 2016July 20, 2016

Eiger Doses First Patient in Phase 2 Trial of PAH Therapy Candidate Bestatin

News, Pulmonary Hypertension

Eiger BioPharmaceuticals has dosed the first patient in its Phase 2 LIBERTY study with the company’s product candidate ubenimex (Bestatin). The trial will assess Bestatin’s effects when added to standard of care treatment in people ... Read more